Chemed Statistics
Total Valuation
Chemed has a market cap or net worth of $6.94 billion. The enterprise value is $7.19 billion.
| Market Cap | 6.94B |
| Enterprise Value | 7.19B |
Important Dates
The last earnings date was Tuesday, July 28, 2026, after market close.
| Earnings Date | Jul 28, 2026 |
| Ex-Dividend Date | Aug 17, 2026 |
Share Statistics
Chemed has 13.02 million shares outstanding. The number of shares has decreased by -7.32% in one year.
| Current Share Class | 13.02M |
| Shares Outstanding | 13.02M |
| Shares Change (YoY) | -7.32% |
| Shares Change (QoQ) | -3.59% |
| Owned by Insiders (%) | 1.49% |
| Owned by Institutions (%) | 107.79% |
| Float | 12.72M |
Valuation Ratios
The trailing PE ratio is 26.79 and the forward PE ratio is 20.56. Chemed's PEG ratio is 1.82.
| PE Ratio | 26.79 |
| Forward PE | 20.56 |
| PS Ratio | 2.69 |
| Forward PS | 2.50 |
| PB Ratio | 8.42 |
| P/TBV Ratio | 133.13 |
| P/FCF Ratio | 21.60 |
| P/OCF Ratio | 17.93 |
| PEG Ratio | 1.82 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.43, with an EV/FCF ratio of 22.39.
| EV / Earnings | 26.35 |
| EV / Sales | 2.79 |
| EV / EBITDA | 17.43 |
| EV / EBIT | 20.75 |
| EV / FCF | 22.39 |
Financial Position
The company has a current ratio of 0.91, with a Debt / Equity ratio of 0.35.
| Current Ratio | 0.91 |
| Quick Ratio | 0.72 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | 0.71 |
| Debt / FCF | 0.91 |
| Interest Coverage | 106.49 |
Financial Efficiency
Return on equity (ROE) is 27.11% and return on invested capital (ROIC) is 24.55%.
| Return on Equity (ROE) | 27.11% |
| Return on Assets (ROA) | 13.45% |
| Return on Invested Capital (ROIC) | 24.55% |
| Return on Capital Employed (ROCE) | 27.72% |
| Weighted Average Cost of Capital (WACC) | 6.81% |
| Revenue Per Employee | $164,126 |
| Profits Per Employee | $17,393 |
| Employee Count | 15,811 |
| Asset Turnover | 1.57 |
| Inventory Turnover | 206.90 |
Taxes
In the past 12 months, Chemed has paid $94.17 million in taxes.
| Income Tax | 94.17M |
| Effective Tax Rate | 25.51% |
Stock Price Statistics
The stock price has increased by +22.74% in the last 52 weeks. The beta is 0.51, so Chemed's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | +22.74% |
| 50-Day Moving Average | 483.51 |
| 200-Day Moving Average | 440.12 |
| Relative Strength Index (RSI) | 58.73 |
| Average Volume (20 Days) | 165,199 |
Short Selling Information
The latest short interest is 566,002, so 4.35% of the outstanding shares have been sold short.
| Short Interest | 566,002 |
| Short Previous Month | 602,352 |
| Short % of Shares Out | 4.35% |
| Short % of Float | 4.45% |
| Short Ratio (days to cover) | 2.76 |
Income Statement
In the last 12 months, Chemed had revenue of $2.60 billion and earned $274.99 million in profits. Earnings per share was $19.91.
| Revenue | 2.60B |
| Gross Profit | 859.31M |
| Operating Income | 354.80M |
| Pretax Income | 369.16M |
| Net Income | 274.99M |
| EBITDA | 415.61M |
| EBIT | 349.19M |
| Earnings Per Share (EPS) | $19.91 |
Balance Sheet
The company has $40.22 million in cash and $294.79 million in debt, with a net cash position of -$254.57 million or -$19.56 per share.
| Cash & Cash Equivalents | 40.22M |
| Total Debt | 294.79M |
| Net Cash | -254.57M |
| Net Cash Per Share | -$19.56 |
| Equity (Book Value) | 830.51M |
| Book Value Per Share | 63.81 |
| Working Capital | -28.61M |
Cash Flow
In the last 12 months, operating cash flow was $389.95 million and capital expenditures -$66.35 million, giving a free cash flow of $323.61 million.
| Operating Cash Flow | 389.95M |
| Capital Expenditures | -66.35M |
| Depreciation & Amortization | 62.12M |
| Net Borrowing | 173.97M |
| Free Cash Flow | 323.61M |
| FCF Per Share | $24.86 |
Margins
Gross margin is 33.11%, with operating and profit margins of 13.67% and 10.60%.
| Gross Margin | 33.11% |
| Operating Margin | 13.67% |
| Pretax Margin | 14.23% |
| Profit Margin | 10.60% |
| EBITDA Margin | 16.02% |
| EBIT Margin | 13.46% |
| FCF Margin | 12.47% |
Dividends & Yields
This stock pays an annual dividend of $2.40, which amounts to a dividend yield of 0.45%.
| Dividend Per Share | $2.40 |
| Dividend Yield | 0.45% |
| Dividend Growth (YoY) | 19.05% |
| Years of Dividend Growth | 17 |
| Payout Ratio | 12.56% |
| Buyback Yield | 7.32% |
| Shareholder Yield | 7.76% |
| Earnings Yield | 3.93% |
| FCF Yield | 4.63% |
Analyst Forecast
The average price target for Chemed is $552.00, which is 3.52% higher than the current price. The consensus rating is "Hold".
| Price Target | $552.00 |
| Price Target Difference | 3.52% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 6.45% |
| EPS Growth Forecast (3Y) | 10.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 12, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | May 12, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Chemed has an Altman Z-Score of 9.97 and a Piotroski F-Score of 5.
| Altman Z-Score | 9.97 |
| Piotroski F-Score | 5 |